Physician profile
Daniel D Michaels
NPI 1073615373
$302.18
in general payments reported to CMS, 2019-2025
13 companies · $32.72 in 2025
The $32.72 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.11 · 2021: $82.46 · 2022: $117 · 2023: $15.13 · 2024: $31.35 · 2025: $32.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $47.38 | 2021 | |
| Ossio INC | $34.61 | 2022 | |
| Mimedx Group, INC. | $31.80 | 2024-2025 | |
| Bioventus LLC | $29.97 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Misonix INC | $23.11 | 2020 | |
| Triad Life Sciences INC. | $20.48 | 2022 | |
| Hikma Pharmaceuticals USA | $19.44 | 2021 | |
| Hartmann USA, INC. | $18.75 | 2022 | |
| Medtronic, INC. | $17.36 | 2025 | Inceptiv |
| Stryker Corporation | $15.64 | 2021 | |
| Smith+Nephew, INC. | $15.13 | 2023 | Collagenase Santyl |
| Medela LLC | $14.80 | 2022 | |
| Nevro Corp. | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Michaels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.